Cargando…

IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT

BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Oude Rengerink, Katrien, Opmeer, Brent C, Logtenberg, Sabine LM, Hooft, Lotty, Bloemenkamp, Kitty WM, Haak, Monique C, Oudijk, Martijn A, Spaanderman, Marc E, Duvekot, Johannes J, Willekes, Christine, van Pampus, Maria G, Porath, Martina M, van Eyck, Jim, Sikkema, Marko J, Mol, Ben Willem J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955658/
https://www.ncbi.nlm.nih.gov/pubmed/20875119
http://dx.doi.org/10.1186/1471-2288-10-85
_version_ 1782188061797384192
author Oude Rengerink, Katrien
Opmeer, Brent C
Logtenberg, Sabine LM
Hooft, Lotty
Bloemenkamp, Kitty WM
Haak, Monique C
Oudijk, Martijn A
Spaanderman, Marc E
Duvekot, Johannes J
Willekes, Christine
van Pampus, Maria G
Porath, Martina M
van Eyck, Jim
Sikkema, Marko J
Mol, Ben Willem J
author_facet Oude Rengerink, Katrien
Opmeer, Brent C
Logtenberg, Sabine LM
Hooft, Lotty
Bloemenkamp, Kitty WM
Haak, Monique C
Oudijk, Martijn A
Spaanderman, Marc E
Duvekot, Johannes J
Willekes, Christine
van Pampus, Maria G
Porath, Martina M
van Eyck, Jim
Sikkema, Marko J
Mol, Ben Willem J
author_sort Oude Rengerink, Katrien
collection PubMed
description BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies. METHODS/DESIGN: We will perform two cohort studies and a case-control study in the Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants - aggregated at centre level - for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time. DISCUSSION: This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials.
format Text
id pubmed-2955658
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29556582010-10-16 IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT Oude Rengerink, Katrien Opmeer, Brent C Logtenberg, Sabine LM Hooft, Lotty Bloemenkamp, Kitty WM Haak, Monique C Oudijk, Martijn A Spaanderman, Marc E Duvekot, Johannes J Willekes, Christine van Pampus, Maria G Porath, Martina M van Eyck, Jim Sikkema, Marko J Mol, Ben Willem J BMC Med Res Methodol Study Protocol BACKGROUND: One of the most commonly reported problems of randomised trials is that recruitment is usually slower than expected. Trials will cost more and take longer, thus delaying the use of the results in clinical practice, and incomplete samples imply decreased statistical power and usefulness of its results. We aim to identify barriers and facilitators for successful patient recruitment at the level of the patient, the doctor and the hospital organization as well as the organization and design of trials over a broad range of studies. METHODS/DESIGN: We will perform two cohort studies and a case-control study in the Netherlands. The first cohort study will report on a series of multicenter trials performed in a nationwide network of clinical trials in obstetrics and gynaecology. A questionnaire will be sent to all clinicians recruiting for these trials to identify determinants - aggregated at centre level - for the recruitment rate. In a case control-study nested in this cohort we will interview patients who refused or consented participation to identify factors associated with patients' consent or refusal. In a second cohort study, we will study trials that were prospectively registered in the Netherlands Trial Register. Using a questionnaire survey we will assess whether issues on hospital organization, trial organization, planning and trial design were associated with successful recruitment, i.e. 80% of the predefined number of patients recruited within the planned time. DISCUSSION: This study will provide insight in barriers and facilitators for successful patient recruitment in trials. The results will be used to provide recommendations and a checklist for individual trialists to identify potential pitfalls for recruitment and judge the feasibility prior to the start of the study. Identified barriers and motivators coupled to evidence-based interventions can improve recruitment of patients in clinical trials. BioMed Central 2010-09-27 /pmc/articles/PMC2955658/ /pubmed/20875119 http://dx.doi.org/10.1186/1471-2288-10-85 Text en Copyright ©2010 Oude Rengerink et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Oude Rengerink, Katrien
Opmeer, Brent C
Logtenberg, Sabine LM
Hooft, Lotty
Bloemenkamp, Kitty WM
Haak, Monique C
Oudijk, Martijn A
Spaanderman, Marc E
Duvekot, Johannes J
Willekes, Christine
van Pampus, Maria G
Porath, Martina M
van Eyck, Jim
Sikkema, Marko J
Mol, Ben Willem J
IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title_full IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title_fullStr IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title_full_unstemmed IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title_short IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT
title_sort improving participation of patients in clinical trials - rationale and design of impact
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955658/
https://www.ncbi.nlm.nih.gov/pubmed/20875119
http://dx.doi.org/10.1186/1471-2288-10-85
work_keys_str_mv AT ouderengerinkkatrien improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT opmeerbrentc improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT logtenbergsabinelm improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT hooftlotty improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT bloemenkampkittywm improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT haakmoniquec improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT oudijkmartijna improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT spaandermanmarce improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT duvekotjohannesj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT willekeschristine improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT vanpampusmariag improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT porathmartinam improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT vaneyckjim improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT sikkemamarkoj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact
AT molbenwillemj improvingparticipationofpatientsinclinicaltrialsrationaleanddesignofimpact